Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis

被引:0
|
作者
Sarah L Jongbloed
M Cristina Lebre
Alasdair R Fraser
J Alastair Gracie
Roger D Sturrock
Paul P Tak
Iain B McInnes
机构
[1] Infection and Inflammation,Division of Immunology
[2] Academic Medical Center/University of Amsterdam,Director, Academic Medical Center, Division of Clinical Immunology and Rheumatology
关键词
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Rheumatoid Arthritis Synovial Fluid; Synovial Fluid Sample; Glasgow Royal Infirmary;
D O I
暂无
中图分类号
学科分类号
摘要
Dendritic cells (DCs) comprise heterogeneous subsets of professional antigen-presenting cells, linking innate and adaptive immunity. Analysis of DC subsets has been hampered by a lack of specific DC markers and reliable quantitation assays. We characterised the immunophenotype and functional characteristics of psoriatic arthritis (PsA)-derived and rheumatoid arthritis (RA)-derived myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) to evaluate their potential role in arthritis. Circulating peripheral blood (PB) pDC numbers were significantly reduced in PsA patients (P = 0.0098) and RA patients (P = 0.0194), and mDCs were significantly reduced in RA patients (P = 0.0086) compared with healthy controls. The number of circulating mDCs in RA PB was significantly inversely correlated to C-reactive protein (P = 0.021). The phenotype of both DC subsets in PsA PB and RA PB was immature as compared with healthy controls. Moreover, CD62L expression was significantly decreased on both mDCs (PsA, P = 0.0122; RA, P = 0.0371) and pDCs (PsA, P = 0.0373; RA, P = 0.0367) in PB. Both mDCs and pDCs were present in PsA synovial fluid (SF) and RA SF, with the mDC:pDC ratio significantly exceeding that in matched PB (PsA SF, P = 0.0453; RA SF, P = 0.0082). pDCs isolated from RA SF and PsA SF displayed an immature phenotype comparable with PB pDCs. RA and PsA SF mDCs, however, displayed a more mature phenotype (increased expression of CD80, CD83 and CD86) compared with PB mDCs. Functional analysis revealed that both SF DC subsets matured following toll-like receptor stimulation. pDCs from PB and SF produced interferon alpha and tumour necrosis factor alpha on TLR9 stimulation, but only SF pDCs produced IL-10. Similarly, mDCs from PB and SF produced similar tumour necrosis factor alpha levels to TLR2 agonism, whereas SF mDCs produced more IL-10 than PB controls. Circulating DC subset numbers are reduced in RA PB and PsA PB with reduced CD62L expression. Maturation is incomplete in the inflamed synovial compartment. Immature DCs in SF may contribute to the perpetuation of inflammation via sampling of the inflamed synovial environment, and in situ presentation of arthritogenic antigen.
引用
收藏
相关论文
共 50 条
  • [21] Distinguishing rheumatoid arthritis from psoriatic arthritis
    Merola, Joseph F.
    Espinoza, Luis R.
    Fleischmann, Roy
    [J]. RMD OPEN, 2018, 4 (02):
  • [22] Distinct Lipidomic Signatures in Synovium and Synovial Fluid of Patients with Rheumatoid Arthritis versus Psoriatic Arthritis
    Rocha, Beatriz
    Cillero-Pastor, Berta
    Illiano, Anna
    Calamia, Valentina
    Pinto, Gabriella
    Amoresano, Angela
    Ruiz-Romero, Cristina
    Canete, Juan D.
    Heeren, Ron Ma
    Blanco-Garcia, Francisco
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1970 - 1972
  • [23] Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis
    Helliwell, P. S.
    Porter, G.
    Taylor, W. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (01) : 113 - 117
  • [24] DIFFERENTIAL MIRNA EXPRESSION AND ENDOTHELIAL CELL FUNCTION IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
    Tynan, O.
    Cunningham, C.
    Hanlon, M.
    Floudas, A.
    Canavan, M.
    Fearon, U.
    Veale, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 464 - 465
  • [25] Tolerogenic dendritic cell therapy for rheumatoid arthritis
    Anderson, Amy E.
    Sayers, Bethan L.
    Swan, David J.
    Isaacs, John D.
    Hilkens, Catharien M.
    [J]. RHEUMATOLOGY, 2008, 47 : II64 - II64
  • [26] Tolerogenic dendritic cell therapy for rheumatoid arthritis
    Anderson, A. E.
    Swan, D. J.
    Harry, R. A.
    Sayers, B. L.
    Robinson, J. H.
    Isaacs, J. D.
    Hilkens, C. M.
    [J]. IMMUNOLOGY, 2008, 125 : 127 - 127
  • [27] TOFACITINIB IMPAIRS MONOCYTE-DERIVED DENDRITIC CELL DIFFERENTIATION IN RHEUMATOID ARTHRITISAND PSORIATIC ARTHRITIS
    Marzaioli, V.
    Canavan, M.
    Floudas, A.
    Wade, S.
    Low, C.
    Veale, D. J.
    Fearon, U.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : A28 - A28
  • [28] TOFACITINIB IMPAIRS MONOCYTE-DERIVED DENDRITIC CELL DIFFERENTIATION IN RHEUMATOID ARTHRITISAND PSORIATIC ARTHRITIS
    Marzaioli, V.
    Canavan, M.
    Wade, S.
    Low, C.
    Veale, D. J.
    Fearon, U.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1223 - 1223
  • [29] Follicular dendritic cell differentiation is associated with distinct synovial pathotype signatures in rheumatoid arthritis
    El Shikh, Mohey Eldin M.
    El Sayed, Riham
    Aly, Nesreen Amer Ramadan
    Prediletto, Edoardo
    Hands, Rebecca
    Fossati-Jimack, Liliane
    Bombardieri, Michele
    Lewis, Myles J.
    Pitzalis, Costantino
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [30] Biomarkers for rheumatoid and psoriatic arthritis
    Verheul, M. K.
    Fearon, U.
    Trouw, L. A.
    Veale, D. J.
    [J]. CLINICAL IMMUNOLOGY, 2015, 161 (01) : 2 - 10